Erratum: Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells (Journal of Infectious Diseases. (2011) Suppl 3 (S840-9) DOI: 10.1093/infdis/jir306);Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 3, 2011, Pages e505-

  Kühl, Annika ^a   Hoffmann, Markus ^b   Müller, Marcel A ^c   Munster, Vincent J ^d   Gnirß, Kerstin ^a   Kiene, Miriam ^a   Tsegaye, Theodros Solomon ^a   Behrens, Georg ^a   Herrler, Georg ^b   Feldmann, Heinz ^d   Drosten, Christian ^c   Pöhlmann, Stefan ^a,e  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e GERMAN PRIMATE CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN;

AFRICAN FRUIT BAT; ANIMAL CELL; BAT; CONFERENCE PAPER; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; VIRAL TROPISM; VIRUS CARRIER; VIRUS ENTRY; VIRUS RELEASE;

EID: 80054736333     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiae337     Document Type: Erratum

References (42)

1. Geisbert TW, Hensley LE. Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions. Expert Rev Mol Med 2004; 6:1-24.
2. Kuhn JH. Filoviruses: a compendium of 40 years of epidemiological, clinical, and laboratory studies. Arch Virol Suppl 2008; 20:13-360.
3. Towner JS, Sealy TK, Khristova ML, et al. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog 2008; 4:e1000212.
4. Hoenen T, Groseth A, Falzarano D, Feldmann H. Ebola virus: unravelling pathogenesis to combat a deadly disease. Trends Mol Med 2006; 12:206-15. (Pubitemid 43728410)
5. Barrette RW, Metwally SA, Rowland JM, et al. Discovery of swine as a host for the Reston ebolavirus. Science 2009; 325:204-6.
6. Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003; 163:2347-70. (Pubitemid 37466478)
7. Wool-Lewis RJ, Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol 1998; 72:3155-60. (Pubitemid 28175558)
8. Yang Z, Delgado R, Xu L, et al. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science 1998; 279:1034-7. (Pubitemid 28113305)
9. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005; 308:1643-5. (Pubitemid 40807517)
10. Neumann G, Feldmann H, Watanabe S, Lukashevich I, Kawaoka Y. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol 2002; 76:406-10. (Pubitemid 33139025)
11. Neumann G, Geisbert TW, Ebihara H, et al. Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. J Virol 2007; 81:2995-8. (Pubitemid 46447062)
12. Licata JM, Johnson RF, Han Z, Harty RN. Contribution of Ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles. J Virol 2004; 78:7344-51. (Pubitemid 38915880)
13. Noda T, Sagara H, Suzuki E, Takada A, Kida H, Kawaoka Y. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol 2002; 76:4855-65. (Pubitemid 34441691)
14. Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci U S A 2000; 97:13871-6.
15. Jasenosky LD, Neumann G, Lukashevich I, Kawaoka Y. Ebola virus VP40-induced particle formation and association with the lipid bilayer. J Virol 2001; 75:5205-14. (Pubitemid 32448543)
16. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P. Tetherinmediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci U S A 2009; 106:2886-91.
17. Simmons G, Wool-Lewis RJ, Baribaud F, Netter RC, Bates P. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol 2002; 76:2518-28. (Pubitemid 34150720)
18. Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 2000; 6:886-9. (Pubitemid 30644746)
19. Geisbert TW, Young HA, Jahrling PB, et al. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 2003; 163:2371-82. (Pubitemid 37474154)
20. Leroy EM, Rouquet P, Formenty P, et al. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 2004; 303:387-90. (Pubitemid 38095781)
21. Leroy EM, Kumulungui B, Pourrut X, et al. Fruit bats as reservoirs of Ebola virus. Nature 2005; 438:575-6. (Pubitemid 41740557)
22. Hayman DT, Emmerich P, Yu M, et al. Long-term survival of an urban fruit bat seropositive for Ebola and Lagos bat viruses. PLoS One 2010; 5:e11978.
23. Pourrut X, Souris M, Towner JS, et al. Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect Dis 2009; 9:159.
24. Swanepoel R, Leman PA, Burt FJ, et al. Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis 1996; 2:321-5. (Pubitemid 126445002)
25. Li W, Wong SK, Li F, et al. Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J Virol 2006; 80:4211-9.
26. Glowacka I, Bertram S, Muller MA, et al. Evidence that TMPRSS2 activates the SARS-coronavirus spike-protein for membrane fusion and reduces viral control by the humoral immune response. J Virol 2011; 85:4122-34.
27. Hanika A, Larisch B, Steinmann E, Schwegmann-Wessels C, Herrler G, Zimmer G. Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes. J Gen Virol 2005; 86:1455-65. (Pubitemid 40613264)
28. Vallo P, Guillén-Servent A, Benda P, Pires DB, Koubek P. Variation of mitochondrial DNA reveals high cryptic diversity in Hipposideros caffer complex. Acta Chiropt 2008; 10:193-206.
29. Hofmann A, Kessler B, Ewerling S, et al. Epigenetic regulation of lentiviral transgene vectors in a large animal model. Mol Ther 2006; 13:59-66. (Pubitemid 41763483)
30. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108:193-9.
31. Banning C, Votteler J, Hoffmann D, et al. A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells. PLoS One 2010; 5:e9344.
32. Gao F, Li Y, Decker JM, et al. Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice. AIDS Res Hum Retroviruses 2003; 19:817-23. (Pubitemid 37215137)
33. Martin-Serrano J, Zang T, Bieniasz PD. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med 2001; 7:1313-9. (Pubitemid 34007935)
34. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008; 451:425-30. (Pubitemid 351158893)
35. Chesebro B, Wehrly K, Nishio J, Perryman S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 1992; 66:6547-54.
36. Krahling V, Dolnik O, Kolesnikova L, et al. Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection. PLoS Negl Trop Dis 2010; 4:e802.
37. Volchkov VE, Feldmann H, Volchkova VA, Klenk HD. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A 1998; 95:5762-7.
38. Bavari S, Bosio CM, Wiegand E, et al. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 2002; 195:593-602. (Pubitemid 34461504)
39. Alazard-Dany N, Volchkova V, Reynard O, et al. Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level. J Gen Virol 2006; 87:1247-57.
40. Jouvenet N, Neil SJ, Zhadina M, et al. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 2009; 83:1837-44.
41. Strong JE, Wong G, Jones SE, et al. Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway. Proc Natl Acad Sci U S A 2008; 105:17982-7.
42. Towner JS, Pourrut X, Albarino CG, et al. Marburg virus infection detected in a common African bat. PLoS One 2007; 2:e764.